Manchester Capital Management LLC Neogenomics Inc Transaction History
Manchester Capital Management LLC
- $814 Million
- Q2 2024
A detailed history of Manchester Capital Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Manchester Capital Management LLC holds 142 shares of NEO stock, worth $2,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142
Previous 142
-0.0%
Holding current value
$2,059
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$205 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$127 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$97.6 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$96 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.82B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...